rs74615166

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_016213.5(TRIP4):​c.1575+7660T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0157 in 152,250 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.016 ( 25 hom., cov: 32)

Consequence

TRIP4
NM_016213.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.328

Publications

16 publications found
Variant links:
Genes affected
TRIP4 (HGNC:12310): (thyroid hormone receptor interactor 4) This gene encodes a subunit of the tetrameric nuclear activating signal cointegrator 1 (ASC-1) complex, which associates with transcriptional coactivators, nuclear receptors and basal transcription factors to facilitate nuclear receptors-mediated transcription. This protein is localized in the nucleus and contains an E1A-type zinc finger domain, which mediates interaction with transcriptional coactivators and ligand-bound nuclear receptors, such as thyroid hormone receptor and retinoid X receptor alpha, but not glucocorticoid receptor. Mutations in this gene are associated with spinal muscular atrophy with congenital bone fractures-1 (SMABF1). [provided by RefSeq, Apr 2016]
TRIP4 Gene-Disease associations (from GenCC):
  • prenatal-onset spinal muscular atrophy with congenital bone fractures
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • spinal muscular atrophy with congenital bone fractures 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0157 (2397/152250) while in subpopulation SAS AF = 0.0247 (119/4820). AF 95% confidence interval is 0.0211. There are 25 homozygotes in GnomAd4. There are 1208 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 25 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRIP4NM_016213.5 linkc.1575+7660T>C intron_variant Intron 11 of 12 ENST00000261884.8 NP_057297.2 Q15650
TRIP4NM_001321924.2 linkc.885+7660T>C intron_variant Intron 11 of 12 NP_001308853.1 Q15650
TRIP4NR_135855.2 linkn.1476+7660T>C intron_variant Intron 10 of 11

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRIP4ENST00000261884.8 linkc.1575+7660T>C intron_variant Intron 11 of 12 1 NM_016213.5 ENSP00000261884.3 Q15650
TRIP4ENST00000558162.1 linkc.132+7660T>C intron_variant Intron 2 of 3 3 ENSP00000452764.1 H0YKD9
TRIP4ENST00000560475.1 linkc.111-11715T>C intron_variant Intron 1 of 2 3 ENSP00000454558.1 H3BMU9

Frequencies

GnomAD3 genomes
AF:
0.0158
AC:
2403
AN:
152132
Hom.:
26
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00393
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0158
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0249
Gnomad FIN
AF:
0.0302
Gnomad MID
AF:
0.0478
Gnomad NFE
AF:
0.0218
Gnomad OTH
AF:
0.0225
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0157
AC:
2397
AN:
152250
Hom.:
25
Cov.:
32
AF XY:
0.0162
AC XY:
1208
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.00392
AC:
163
AN:
41560
American (AMR)
AF:
0.0158
AC:
241
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5174
South Asian (SAS)
AF:
0.0247
AC:
119
AN:
4820
European-Finnish (FIN)
AF:
0.0302
AC:
321
AN:
10614
Middle Eastern (MID)
AF:
0.0342
AC:
10
AN:
292
European-Non Finnish (NFE)
AF:
0.0218
AC:
1482
AN:
68012
Other (OTH)
AF:
0.0227
AC:
48
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
119
238
358
477
596
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0176
Hom.:
11
Bravo
AF:
0.0140
Asia WGS
AF:
0.00924
AC:
32
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.77
DANN
Benign
0.61
PhyloP100
-0.33
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74615166; hg19: chr15-64725490; API